{"id":193491,"name":"CALIFORNIA LIFE SCIENCES","slug":"california-life-sciences","state":"DC","country":"United States of America","description":"A public policy research and advocacy organization for California's biomedical industry.","totalSpending":1120000,"filings":32,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":120000},{"year":2022,"income":160000},{"year":2023,"income":160000},{"year":2024,"income":160000},{"year":2025,"income":160000}],"issues":["HCR","BUD","MMM","TAX","DEF","TRD"],"firms":["W STRATEGIES, LLC"],"lobbyists":["DARREN WILLCOX"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Promoted life sciences community and communicated economic and health benefits of the industry.","H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal.\n\nH.R.1625: Consolidated Appropriations Act, 2018.","H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.","H.R. 184: Protect Medical Innovation Act.\n\nFY 2018 Continuing resolution as it relates to suspension of the medical device tax.","H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}